Physician

Robert Lin, MD

According to 2025 Medicare claims, Robert Lin, MD (NPI: 1770018665) practices medical oncology in the Albuquerque, NM market, with the plurality of this provider's patient population coming from Bernalillo, NM. This provider's primary affiliated billing organization is NEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS, LTD. (NPI: 1164475232; TIN: 850367056) and primary practice location at 87109-4495. Lin is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Lin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 654 traditional Medicare patients, billed 97,645 HCPCS/CPT codes, and received $1,845,240 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 516 prescription claims across 142 beneficiaries totaling $645,407 in drug costs, led by Ondansetron Odt (Ondansetron). Open Payments data shows 13 records totaling $276. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,991 to $645,407. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.